/SQIDF
SQIDF Stock - SQI Diagnostics Inc.
Healthcare|Medical - Diagnostics & ResearchOTC
$0.01+14.62%
+$0.00 (+14.62%) • Jun 14
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SQIDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.01
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.36
52W High$0.01
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $8.10M | $917,000 | $1.02M | $1.89M | $1.33M |
| Gross Profit | $3.10M | $767,000 | $791,000 | $1.28M | $458,000 |
| Gross Margin | 38.3% | 83.6% | 77.3% | 67.8% | 34.3% |
| Operating Income | $-19,560,000 | $-10,039,000 | $-7,892,000 | $-7,365,000 | $-6,858,000 |
| Net Income | $-18,523,000 | $-10,557,000 | $-8,571,000 | $-8,021,000 | $-7,437,000 |
| Net Margin | -228.6% | -1151.3% | -837.8% | -424.2% | -557.1% |
| EPS | $-0.05 | $-0.03 | $-0.03 | $-0.04 | $-0.06 |
Company Overview
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, the company offers microarray instruments for antibody testing workflow. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SQIDFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q2 2023
EPS Surprise History
Q3 21
No data
Q1 22
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q1 23
No data
Q1 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 24, 2024 | — | — | — | — |
Q2 2024 | May 13, 2024 | — | — | — | — |
Q1 2024 | Feb 1, 2024 | — | — | — | — |
Q4 2023 | Nov 1, 2023 | — | — | — | — |
Q3 2023 | Sep 26, 2023 | — | — | — | — |
Q2 2023 | May 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 1, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 29, 2023 | — | $-0.01 | — | — |
Q3 2022 | Aug 29, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 25, 2022 | — | $-0.01 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.01 | — | — |
Q1 2022 | Jan 25, 2022 | — | $-0.01 | — | — |
Q3 2021 | Aug 18, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 21, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 1, 2021 | — | $-0.01 | — | — |
Q1 2021 | Jan 27, 2021 | — | $-0.01 | — | — |
Q3 2020 | Aug 27, 2020 | — | $-0.00 | — | — |
Q2 2020 | May 28, 2020 | — | $-0.01 | — | — |
Q1 2020 | Feb 27, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 11, 2019 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SQIDF
What is SQIDF's current stock price?
SQI Diagnostics Inc. (SQIDF) is currently trading at $0.01 per share. The stock has moved +14.62% today.
What is the analyst price target for SQIDF?
No analyst price targets are currently available for this stock.
What sector is SQI Diagnostics Inc. in?
SQI Diagnostics Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is SQIDF's market cap?
SQI Diagnostics Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does SQIDF pay dividends?
No, SQI Diagnostics Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBCBCF
The BC Bud Corporation
$0.04
Mkt Cap: $0.0B
BLMHF
Bloom Health Partners Inc.
$0.11
Mkt Cap: $0.0B
CLSH
CLS Holdings USA, Inc.
$0.04
Mkt Cap: $0.0B
DOCRF
CloudMD Software & Services Inc.
$0.02
Mkt Cap: $0.0B
DTXMF
Deltex Medical Group plc
$0.10
Mkt Cap: $0.2B
FFLWF
Fire & Flower Holdings Corp.
$0.12
Mkt Cap: $0.0B
MXDHF
MDxHealth S.A.
$0.25
Mkt Cap: $0.0B
POLXF
Polydex Pharmaceuticals Limited
$1.99
Mkt Cap: $0.0B
RHNMF
Rhinomed Limited
$0.02
Mkt Cap: $0.0B
VVCIF
VIVO Cannabis Inc.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to SQIDF for comparison